Chapters

Transcript

Video

At what point with PTCL-TFH do you introduce duvelisib treatment? Do you use it in the first-line setting or do you currently reserve it for R/R patients and as a bridge for allograft stem cell transplantion?


Created by

CMEducation Resources iQ&A PTCL Hematology-Oncology Intelligence Zone

Presenter

Christina Poh, MD

Christina Poh, MD

Physician, Fred Hutchinson Cancer CenterAssistant Professor, Division of Hematology and OncologyUniversity of Washington School of MedicineSeattle, Washington